BBOT to Participate in Upcoming December Investor Healthcare Conferences
BridgeBio Oncology Therapeutics (Nasdaq: BBOT) said members of its leadership team will present at two investor healthcare conferences in early December 2025.
Presentation schedule: Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 2:00 PM ET, and Evercore 8th Annual Healthcare Conference on Wednesday, December 3, 2025 at 9:35 AM ET. Live webcasts will be available on the company's Events page, with replays accessible for at least 90 days after each event.
BridgeBio Oncology Therapeutics (Nasdaq: BBOT) ha comunicato che i membri del suo team dirigente interverranno a due conferenze sanitarie per investitori all'inizio di dicembre 2025.
Programma delle presentazioni: Piper Sandler 37th Annual Healthcare Conference il martedì 2 dicembre 2025 alle ore 20:00 ET, e Evercore 8th Annual Healthcare Conference il mercoledì 3 dicembre 2025 alle ore 9:35 ET. Le trasmissioni in diretta saranno disponibili sulla pagina Events dell'azienda, con repliche accessibili per almeno 90 giorni dopo ciascun evento.
BridgeBio Oncology Therapeutics (Nasdaq: BBOT) dijo que los miembros de su equipo de liderazgo presentarán en dos conferencias de atención médica para inversores a principios de diciembre de 2025.
Programa de presentaciones: Piper Sandler 37th Annual Healthcare Conference el martes 2 de diciembre de 2025 a las 2:00 PM ET, y Evercore 8th Annual Healthcare Conference el miércoles 3 de diciembre de 2025 a las 9:35 AM ET. Las transmisiones en vivo estarán disponibles en la página de Events de la empresa, con repeticiones accesibles durante al menos 90 días después de cada evento.
BridgeBio Oncology Therapeutics (Nasdaq: BBOT)은(는) 2025년 12월 초에 두 차례의 투자자 헬스케어 컨퍼런스에 경영진이 발표할 예정이라고 밝혔다.
발표 일정: Piper Sandler 37th Annual Healthcare Conference은 2025년 12월 2일 화요일 오후 2:00 ET, 그리고 Evercore 8th Annual Healthcare Conference은 2025년 12월 3일 수요일 오전 9:35 ET에 진행됩니다. 생중계는 회사의 Events 페이지에서 시청 가능하며, 각 이벤트 이후 최소 90일 동안 다시 보기가 제공됩니다.
BridgeBio Oncology Therapeutics (Nasdaq: BBOT) a annoncé que des membres de son équipe de direction présenteront lors de deux conférences pour investisseurs dans le secteur de la santé au début de décembre 2025.
Programme des présentations: Piper Sandler 37th Annual Healthcare Conference le mardi 2 décembre 2025 à 14h00 ET, et Evercore 8th Annual Healthcare Conference le mercredi 3 décembre 2025 à 9h35 ET. Les webcasts en direct seront disponibles sur la page Events de l'entreprise, avec des replays accessibles pendant au moins 90 jours après chaque événement.
BridgeBio Oncology Therapeutics (Nasdaq: BBOT) gab bekannt, dass Mitglieder des Führungsteams im frühen Dezember 2025 bei zwei Investoren-Konferenzen im Gesundheitswesen auftreten werden.
Präsentationsplan: Piper Sandler 37th Annual Healthcare Conference am Dienstag, 2. Dezember 2025 um 14:00 Uhr ET und Evercore 8th Annual Healthcare Conference am Mittwoch, 3. Dezember 2025 um 9:35 Uhr ET. Live-Webcasts sind auf der Events-Seite des Unternehmens verfügbar, mit Wiederholungen, die für mindestens 90 Tage nach jeder Veranstaltung zugänglich sind.
BridgeBio Oncology Therapeutics (Nasdaq: BBOT) ذكرت أن أعضاء فريق قيادتها سيقدمون في مؤتمرين صحيين للمستثمرين في بداية ديسمبر 2025.
جدول العروض: Piper Sandler 37th Annual Healthcare Conference في الثلاثاء 2 ديسمبر 2025 الساعة 2:00 مساءً بتوقيت شرق الولايات المتحدة، و Evercore 8th Annual Healthcare Conference في الأربعاء 3 ديسمبر 2025 الساعة 9:35 صباحاً بتوقيت شرق الولايات المتحدة. ستتوفر البثوث المباشرة على صفحة الشركة Events مع إمكانية إعادة العرض لمدة لا تقل عن 90 يوماً بعد كل حدث.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in December.
Details of the company’s participation are as follows:
- Piper Sandler 37th Annual Healthcare Conference
Presentation: Tuesday, December 2, at 2:00 p.m. ET
- 8th Annual Evercore Healthcare Conference
Presentation: Wednesday, December 3, at 9:35 a.m. ET
Live webcasts of the presentations will be accessible on the “Events” page of the BBOT website at https://investors.bbotx.com/news-events/events. Replays of the webcasts will be available for at least 90 days following the event.
About BBOT
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, please visit www.bbotx.com and follow us on LinkedIn.
BBOT Contacts:
Investor Contact:
Heather Armstrong
BBOT
Heather.Armstrong@bbotx.com
Media Contact:
Jake Robison
Inizio Evoke Comms
Jake.robison@inizioevoke.com
FAQ
When will BBOT present at the Piper Sandler 37th Annual Healthcare Conference?
When will BBOT present at the Evercore 8th Annual Healthcare Conference?
Where can investors watch BBOT's December 2025 conference presentations?
How long will BBOT conference presentation replays be available?
What topics will BBOT leadership cover at the December 2025 conferences?
